Solventum Co. (NYSE:SOLV) Shares Sold by Focus Financial Network Inc.

Focus Financial Network Inc. lowered its stake in shares of Solventum Co. (NYSE:SOLV) by 11.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,980 shares of the company’s stock after selling 1,526 shares during the quarter. Focus Financial Network Inc.’s holdings in Solventum were worth $791,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Modus Advisors LLC bought a new position in Solventum during the fourth quarter worth $25,000. Copeland Capital Management LLC acquired a new stake in shares of Solventum during the third quarter worth $26,000. Crews Bank & Trust acquired a new position in shares of Solventum in the 4th quarter valued at about $32,000. True Wealth Design LLC grew its position in shares of Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after buying an additional 471 shares during the last quarter. Finally, Prospera Private Wealth LLC acquired a new stake in Solventum during the third quarter worth about $35,000.

Solventum Stock Performance

Shares of SOLV opened at $73.62 on Thursday. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $96.05. The firm has a 50-day moving average price of $70.51 and a 200 day moving average price of $68.32. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Analyst Ratings Changes

Several research firms have recently commented on SOLV. Morgan Stanley upped their target price on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Piper Sandler increased their target price on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Finally, Mizuho began coverage on Solventum in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $68.29.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.